Drug major Sun Pharmaceutical Industries today said it has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules used for the treatment of hypertension, chest pain and heart failure in the US market.
Kapspargo Sprinkle pellets can be sprinkled over soft food or administered via a nasogastric tube, and are designed to facilitate long-term, once-daily administration, particularly for patients who have difficulty swallowing, Sun Pharma said in a BSE filing.
Sun Pharma North America CEO Abhay Gandhi said: "Kapspargo Sprinkle capsules may make it easier for patients to take their antihypertensive medication."
Disclaimer: No Business Standard Journalist was involved in creation of this content